Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma
NCT04724226
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Camrelizumab; Apatinib
Sponsor
Sun Yat-sen University